J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

By Anil K. Chaturvedi, E. Engels, Ruth M. Pfeiffer, B. Hernandez, Weihong Xiao, Esther D. Kim, B. Jiang, M. Goodman, M. Sibug-Saber, W. Cozen and 8 more. 2014

2,560 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Otorhinolaryngology

View Paper: https://www.semanticscholar.org/paper/5e56703604ccfbf4e9860ff5beedf5b9a23c76f0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. F. Bray
2. J. Vignat
3. Silvia Franceschi
4. J. Ferlay
5. X. Castellsagué
6. A. Jemal

In Genetics

1. F. Bray
2. J. Ferlay
3. Martyn Plummer
4. P. Rosenberg

In Otorhinolaryngology

1. X. Castellsagué

Citations in the corpus

• US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. (2015, background): “1% prevalence of HPV in oropharyngeal tumor tissue, a much higher fraction than observed in international settings (40) but consistent with other US studies (6,7).”
• Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence (2014, background): “Furthermore, changes in the biology (e.g., HPV-related cancer of the oropharynx) and epidemiology of cancer (e.g., gastroesophageal cancer) can be best described using observational research (Devesa et al, 1998; Chaturvedi et al, 2011).”
• Worldwide burden of cancer attributable to HPV by site, country and HPV type (2017, background): “The fraction of oropharyngeal cancer related to HPV has been increasing over the past two decades in some highincome countries concomitant to the decline of tobacco smoking and increase of HPV infection.(18) The pattern of anogenital cancers is probably due to a combination of variation in the burde”
• Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma (2023, background): “20 months) [49], independently reducing the risk of death by 64% when adjusted for risk factors [50].”
• Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. (2013, result): “For example, in a recent study of tumors collected by population-based cancer registries in the United States, HPV prevalence was significantly higher among men compared with women.(22) This male predominance is also supported by higher oral HPV prevalence among men than women in the US general popu”
• A review of clinical trials of human papillomavirus prophylactic vaccines. (2012, background): “This deficit is an important consideration, since the incidence of HPV-associated oropharyngeal cancer (mostly attributable to HPV16) appears to be increasing dramatically, at least in industrialized countries [87].”